DSM-Firmenich completes buyback. DSM-Firmenich stock is 4.77 percent below its 52-week high

Published on 10/02/2026 at 15:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The program bought 7,169,147 shares at EUR 75.32. DSM-Firmenich stock costs EUR 94.66 on October 2, 2026 after EUR 95.97, down 1.37 percent.

Bauhaus-Poster mit geometrischen Formen, Molekül und Schriftzug SCIENCE — dsm-firmenich AG (ISIN CH1216478797) erscheint als geometrisches Bauhaus-Poster mit Molekülformen und dem Wort SCIENCE, Illustration mit AI erstellt.

DSM-Firmenich completed its EUR 540 million share repurchase program on October 1, 2026, while DSM-Firmenich stock stood 4.77 percent below its 52-week high. According to Finanznachrichten on October 1, 2026, the company repurchased 7,169,147 shares at an average price of EUR 75.32.

Buyback cuts share count

The program included EUR 40 million for share-based compensation commitments and EUR 500 million for reducing issued capital. DSM-Firmenich plans to cancel 6,488,446 shares by the end of the first quarter of 2027, reducing issued shares from 253,626,947 to 247,138,501.

The planned cancellation represents a 2.60 percent reduction in issued shares. That makes the capital action more concrete than the headline EUR 540 million figure: the investor-relevant effect is the lower share count after cancellation.

Quarterly revenue rises

According to Business Insider, DSM-Firmenich reported revenue of EUR 4.66 billion for the quarter ended June 30, 2026, compared with EUR 3.26 billion in the same period of 2025. Net profit was EUR 212 million, down from EUR 255 million a year earlier.

The figures show a mixed operating signal. Revenue increased by EUR 1.40 billion year over year, while net profit declined by EUR 43 million, leaving the share cancellation and earnings conversion as separate issues for the market.

Stock remains below yearly high

The finance quote for October 2, 2026 gives DSM-Firmenich a market capitalization of EUR 23.3 billion and a 52-week range of EUR 55.22 to EUR 99.40. At EUR 94.66, the stock is EUR 4.74 below that high, a 4.77 percent gap calculated against EUR 99.40.

The company is listed on Euronext Amsterdam and SIX Swiss Exchange, and its next sales and revenue release is scheduled for November 3, 2026, according to MarketScreener. The coming report will provide the next dated test for revenue growth and profit conversion.

EUR 94.66 price reference

DSM-Firmenich was trading at EUR 94.66 at Lang & Schwarz on October 2, 2026 at 3:03 p.m. CEST, down 1.37 percent versus the Lang & Schwarz prior close of EUR 95.97 on October 1, 2026. The further course of trading is shown by the continuously updated real-time quote of DSM-Firmenich stock.